Search Browse Earnings

Pulmonx Corp

Nasdaq:LUNG

Surgical & Medical Instruments & Apparatus·REDWOOD CITY, CA

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

Pulmonx Corp — SlamSEC

Revenue

$68.7M

+28.0% YoY

FY 2024

Adj. EBITDA

-$60.5M

-88.1% margin

FY 2024

Net Income

-$60.8M

-88.6% margin

FY 2024

EPS (Diluted)

-$1.60

FY 2024

Stock Price

$1.82

-9.9%

2026-03-09

52W Range

$1.31 – $8.12

P/E Ratio

-1.1x

Market Cap

$75.1M

Cash

$83.5M

FY 2024

Total Debt

$37.2M

FY 2024

Net Cash

$46.3M

FY 2024

Enterprise Value

$28.8M

Debt / EBITDA

0.8x

FY 2024

EV / EBITDA

-0.5x

Employees

—